Tickertape - Financial freedom begins here
NIFTY 50
24,246.700.34% 82.25SENSEX
79,801.430.39% 315.06- MARKET MOOD10:27
Greed
Market and sectors
See AllNIFTY 100 Largecap | 24,860.400.31% | ||
NIFTY 100 Midcap | 54,920.550.22% | ||
NIFTY 100 Smallcap | 16,959.100.06% |
NIFTY Bank | 55,129.650.43% | ||
NIFTY IT | 35,329.150.24% | ||
NIFTY Pharma | 21,983.301.12% |
NIFTY 100 Largecap | 24,860.400.31% | ||
NIFTY 100 Midcap | 54,920.550.22% | ||
NIFTY 100 Smallcap | 16,959.100.06% |
NIFTY Bank | 55,129.650.43% | ||
NIFTY IT | 35,329.150.24% | ||
NIFTY Pharma | 21,983.301.12% |
Today's stocks
STOCKSPRICECHANGE | |
![]() Divi's Laboratories LtdDIVISLAB | ₹6,215.504.91% |
![]() Adani Energy Solutions LtdADANIENSOL | ₹961.702.44% |
![]() Hindustan Zinc LtdHINDZINC | ₹459.352.29% |
![]() Mankind Pharma LtdMANKIND | ₹2,599.202.11% |
![]() UltraTech Cement LtdULTRACEMCO | ₹12,159.001.76% |
Mutual funds and ETFs
FUNDSRETURNS | |
![]() Equity • Growth | |
![]() 18.90% Equity • Growth | |
![]() 15.16% Equity • Growth | |
![]() Equity • Growth | |
![]() 12.90% Equity • Growth |
Curated screens and deals
Market and sectors
See AllNIFTY 100 Largecap | 24,860.400.31% | ||
NIFTY 100 Midcap | 54,920.550.22% | ||
NIFTY 100 Smallcap | 16,959.100.06% |
NIFTY Bank | 55,129.650.43% | ||
NIFTY IT | 35,329.150.24% | ||
NIFTY Pharma | 21,983.301.12% |
NIFTY 100 Largecap | 24,860.400.31% | ||
NIFTY 100 Midcap | 54,920.550.22% | ||
NIFTY 100 Smallcap | 16,959.100.06% |
NIFTY Bank | 55,129.650.43% | ||
NIFTY IT | 35,329.150.24% | ||
NIFTY Pharma | 21,983.301.12% |
Today's stocks
STOCKSPRICECHANGE | |
![]() Divi's Laboratories LtdDIVISLAB | ₹6,215.504.91% |
![]() Adani Energy Solutions LtdADANIENSOL | ₹961.702.44% |
![]() Hindustan Zinc LtdHINDZINC | ₹459.352.29% |
![]() Mankind Pharma LtdMANKIND | ₹2,599.202.11% |
![]() UltraTech Cement LtdULTRACEMCO | ₹12,159.001.76% |
Curated screens and deals

Net Loss of Jayshree Chemicals reported to Rs 0.16 crore in the quarter ended March 2025 as against net loss of Rs 3.46 crore during the previous quarter ended March 2024. Sales rose 24.19% to Rs 4.21 crore in the quarter ended March 2025 as against Rs 3.39 crore during the previous quarter ended March 2024. For the full year,net loss reported to Rs 0.27 crore in the year ended March 2025 as against net loss of Rs 3.51 crore during the previous year ended March 2024. Sales rose 31.75% to Rs 16.89 crore in the year ended March 2025 as against Rs 12.82 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales4.213.39 24 16.8912.82 32 OPM %-4.51-76.11 --3.49-23.48 - PBDT0-2.38 100 0.21-1.97 LP PBT-0.08-2.44 97 -0.05-2.22 98 NP-0.16-3.46 95 -0.27-3.51 92 Powered by Capital Market - Live

Net profit of SBI Life Insurance Company rose 0.33% to Rs 813.51 crore in the quarter ended March 2025 as against Rs 810.80 crore during the previous quarter ended March 2024. Sales declined 5.00% to Rs 23860.71 crore in the quarter ended March 2025 as against Rs 25116.47 crore during the previous quarter ended March 2024. For the full year,net profit rose 27.43% to Rs 2413.30 crore in the year ended March 2025 as against Rs 1893.78 crore during the previous year ended March 2024. Sales rose 4.31% to Rs 84059.83 crore in the year ended March 2025 as against Rs 80587.10 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales23860.7125116.47 -5 84059.8380587.10 4 OPM %-1.88-3.14 -1.600.50 - PBDT900.63851.13 6 2692.602077.79 30 PBT900.63851.13 6 2692.602077.79 30 NP813.51810.80 0 2413.301893.78 27 Powered by Capital Market - Live
Mutual funds and ETFs
FUNDSRETURNS | |
![]() Equity • Growth | |
![]() 18.90% Equity • Growth | |
![]() 15.16% Equity • Growth | |
![]() Equity • Growth | |
![]() 12.90% Equity • Growth |
Money
Matters
- Assets tracked worth60,500 Cr
- Loved by60 L+ investors
- Downloads6.2M+
- Rated on Google Play4.2
